Literature DB >> 26134558

Diagnostic value of fine needle aspiration and core needle biopsy in special types of breast cancer.

Ryuji Ohashi1, Miyuki Matsubara2, Yasuhiko Watarai2, Keiko Yanagihara3, Koji Yamashita3, Shin-Ichi Tsuchiya2,4, Hiroyuki Takei3, Zenya Naito2,5.   

Abstract

BACKGROUND: Although fine needle aspiration (FNA) biopsy is an established tool to assess breast lesions, there has been a trend toward using core needle biopsy (CNB) instead. The aim of this study was to compare the diagnostic accuracy of FNA and CNB in special types of breast cancer.
METHODS: A retrospective review of diagnostic results of pre-operatively performed FNA or CNB, or a combination of the two, was conducted. The cases include histologically proven invasive ductal carcinoma of no special type (NST n = 159), invasive lobular carcinoma (ILC n = 65), mucinous carcinoma (MUC n = 51), and apocrine carcinoma (APO n = 25).
RESULTS: The absolute diagnostic sensitivity of FNA to detect malignancy in ILC and APO patients was inferior to that of NST patients (p < 0.001 for ILC and APO). Within each cancer type, the sensitivity of CNB was higher than that of FNA in the ILC and APO patients (p < 0.001 and p < 0.05, respectively). As for NST and MUC patients, FNA and CNB had equivalent sensitivity. The sensitivity of FNA alone significantly improved when combined with CNB in NST, ILC and APO patients (p < 0.05, p < 0.001, and p < 0.05, respectively).
CONCLUSIONS: Our results suggest that FNA has less diagnostic accuracy than CNB for ILC and APO; thus, the use of CNB should be encouraged when these types of cancer are clinically suspected or when the initial FNA is inconclusive.

Entities:  

Keywords:  Core needle biopsy; Fine needle aspiration; Special type of cancer

Mesh:

Year:  2015        PMID: 26134558     DOI: 10.1007/s12282-015-0624-9

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  1 in total

1.  Predictive value of ultrasound imaging in differentiating benign from malignant breast lesions taking biopsy results as the standard.

Authors:  Abdulkhaleq A Binnuhaid; Sultan Abdulwadoud Alshoabi; Fahad H Alhazmi; Tareef S Daqqaq; Suliman G Salih; Sami A Al-Dubai
Journal:  J Family Med Prim Care       Date:  2019-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.